Leukaemia UK and Leuka have merged

We are delighted to announce that on 1 November Leuka and Leukaemia UK merged, bringing together two of the UK’s leading leukaemia and blood cancer charities to create one charity dedicated to innovative research and care for people affected by blood cancers. The two charities have joined forces under the name Leukaemia UK, uniting Leuka’s 37 years’ experience in ground-breaking medical research with Leukaemia UK’s four decades of pioneering care.

From research to care, the new charity will continue to put people affected by blood cancers at its heart. Together, Leukaemia UK aims to carry out even more world-class research and advances in care.

Leukaemia UK will be led jointly by Leuka's CEO Olive Boles and Leukaemia UK's CEO Angela Smith-Morgan. The charity's new Chair of Trustees is Chris Corbin, current Chair of Leuka, who is supported by a Board including both Leuka and Leukaemia UK Trustees.

Latest

Leading leukaemia charities call on Rishi Sunak not to cut financial lifeline for blood cancer patients

Leukaemia Care, Leukaemia UK and Leukaemia and Lymphoma Northern Ireland, have written to the Chancellor urging him to realise the devastating impact the end of the Coronavirus Job Retention Scheme will have on the clinically extremely vulnerable (CEV).
Georgia King

Supporter Care Officer
Quiz and dinner

like raising
Tom Bairstow’s Half Marathon to raise money for Leukaemia UK

I’m running the Royal Parks Half Marathon to raise money for Leukaemia UK

Leading leukaemia charities call on Rishi Sunak not to cut financial lifeline for blood cancer patients

Leukaemia Care, Leukaemia UK and Leukaemia and Lymphoma Northern Ireland, have written to the Chancellor urging him to realise the devastating impact the end of the Coronavirus Job Retention Scheme will have on the clinically extremely vulnerable (CEV).
Open letter from cancer charities to the public

40 charities and organisations have written an open letter, urging the public to help keep vulnerable people safe as restrictions ease.
Leukaemia UK funded scientist has developed a new class of cancer drug with the potential to treat leukaemia

Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia.
Leukaemia UK appoints new CEO

The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, starting her role on 9th September 2020.
Angela Smith-Morgan to step down from her role as Co CEO of Leukaemia UK

After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September.
We are funding further vital research: John Goldman Fellowships 2020

At Leukaemia UK, we remain committed to funding crucial research into leukaemia and other blood cancers, even during this unprecedented time which is affecting so many aspects of our lives
A new clinical trial announced

A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.
Calling our supporters to join The 2.6 Challenge

Leukaemia UK, like so many charities across the UK, has been hugely impacted by the cancellation of thousands of fundraising events due to COVID-19. Join this new campaign to help to raise vital funds for our cause.
Coronavirus (COVID-19): Information

We understand that people affected by leukaemia or other blood cancers may have questions and queries about coronavirus (COVID-19)
Championing groundbreaking therapies and emotional support

We are proud to be at the forefront of funding innovative research into gene therapy treatments